API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. 1051366-32-5
2. Pol6326
3. Cyclo(l-alanyl-l-cysteinyl-l-seryl-l-alanyl-d-prolyl-(2s)-2,4-diaminobutanoyl-l-arginyl-l-tyrosyl-l-cysteinyl-l-tyrosyl-l-glutaminyl-l-lysyl-d-prolyl-l-prolyl-l-tyrosyl-l-histidyl), Cyclic (2->9)-disulfide
4. Balixafortide [inn]
5. Balixafortide [usan]
6. Balixafortide(pol6326)
7. Balixafortide (pol6326)
8. Unii-prc974m49b
9. Prc974m49b
10. Gtpl11587
11. Pol 6326
12. Who 9915
13. S9725
14. Ala-cys-ser-ala-pro-arg-tyr-cys-tyr-gln-lys-pro-pro-tyr-his Cyclic (2->9)-disulfide
Molecular Weight | 1864.1 g/mol |
---|---|
Molecular Formula | C84H118N24O21S2 |
XLogP3 | -3.5 |
Hydrogen Bond Donor Count | 24 |
Hydrogen Bond Acceptor Count | 29 |
Rotatable Bond Count | 23 |
Exact Mass | 1862.83447922 g/mol |
Monoisotopic Mass | 1862.83447922 g/mol |
Topological Polar Surface Area | 757 Ų |
Heavy Atom Count | 131 |
Formal Charge | 0 |
Complexity | 3970 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 16 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of breast cancer